Phenotypic and Genotypic Characterization of Escherichia Coli
June 12, 2024 updated by: Yassmin Hassan Mahmoud, Sohag University
Phenotypic and Genotypic and Antimicrobial Resistance Characterization of Escherichia Coli Causing Nosocomial Urinary Tract Infections in Sohag University Hospitals ,Egypt
Collection of urine samples Cultivation Antibiotic sensitivity test PCR
Study Overview
Status
Not yet recruiting
Detailed Description
Cultivation on MaCconkey and EMB IMVC test Dis diffusion test Detection of virulence and antibiotic resistance genes by PCR
Study Type
Observational
Enrollment (Estimated)
100
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Adults only with hospital acquired infections
Description
Inclusion Criteria:
- Catheter associated urinary tract infections in patient with catheter more than two 2 days .fever.urine culture with no more than 2 species organisation catheterization .fever.suprapubic tenderness with urine culture more than 105 CFU/Ml
Exclusion Criteria:
- asymptomatic bacteriuria UTI before 48 hrs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Group 1
Escherichia coli isolates
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Antibiotic sensitivity testing whether sensitive .intermediately sensitive and resistance
Time Frame: 6 month
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2024
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
March 1, 2025
Study Registration Dates
First Submitted
June 9, 2024
First Submitted That Met QC Criteria
June 12, 2024
First Posted (Actual)
June 17, 2024
Study Record Updates
Last Update Posted (Actual)
June 17, 2024
Last Update Submitted That Met QC Criteria
June 12, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Soh-Med-24-03-01MS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antibiotic Sensitivity Testing and Genotypic Caharacterization of Ecoli
-
Sohag UniversityNot yet recruitingISOLATION OF KLEB. by Culture on macConkey Agar | Antibiotic Sensitivity Testing of Different Antibiotics According to Clsi 25 | Effect of Ceftazidime-Avibactam on Carbapenemase-Producing Klebsiella Pneumoniae | Detection of Resistance Gene in Isolates Using Conventional Pcr | Detection...Egypt